These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 12230626

  • 1. Vitamin D receptor-dependent antitumour effects of 1,25-dihydroxyvitamin D3 and two synthetic analogues in three in vivo models of prostate cancer.
    Oades GM, Dredge K, Kirby RS, Colston KW.
    BJU Int; 2002 Oct; 90(6):607-16. PubMed ID: 12230626
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
    Chen TC, Holick MF, Lokeshwar BL, Burnstein KL, Schwartz GG.
    Recent Results Cancer Res; 2003 Oct; 164():273-88. PubMed ID: 12899529
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L.
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH, Light BW, Lapco PE, Konety BR, Nangia AK, Acierno JS, Dhir R, Shurin Z, Day RS, Trump DL, Johnson CS.
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [Abstract] [Full Text] [Related]

  • 5. A calcitriol analogue, EB1089, inhibits the growth of LNCaP tumors in nude mice.
    Blutt SE, Polek TC, Stewart LV, Kattan MW, Weigel NL.
    Cancer Res; 2000 Feb 15; 60(4):779-82. PubMed ID: 10706079
    [Abstract] [Full Text] [Related]

  • 6. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
    Golovko O, Nazarova N, Tuohimaa P.
    Life Sci; 2005 Jun 17; 77(5):562-77. PubMed ID: 15904673
    [Abstract] [Full Text] [Related]

  • 7. Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity.
    Danielsson C, Mathiasen IS, James SY, Nayeri S, Bretting C, Hansen CM, Colston KW, Carlberg C.
    J Cell Biochem; 1997 Sep 15; 66(4):552-62. PubMed ID: 9282333
    [Abstract] [Full Text] [Related]

  • 8. EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.
    Bhatia V, Saini MK, Shen X, Bi LX, Qiu S, Weigel NL, Falzon M.
    Mol Cancer Ther; 2009 Jul 15; 8(7):1787-98. PubMed ID: 19584236
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A.
    Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699
    [Abstract] [Full Text] [Related]

  • 10. Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma.
    Prudencio J, Akutsu N, Benlimame N, Wang T, Bastien Y, Lin R, Black MJ, Alaoui-Jamali MA, White JH.
    J Natl Cancer Inst; 2001 May 16; 93(10):745-53. PubMed ID: 11353784
    [Abstract] [Full Text] [Related]

  • 11. 1,25-Dihydroxy-16-ene-23-yne-vitamin D3 and prostate cancer cell proliferation in vivo.
    Schwartz GG, Hill CC, Oeler TA, Becich MJ, Bahnson RR.
    Urology; 1995 Sep 16; 46(3):365-9. PubMed ID: 7660511
    [Abstract] [Full Text] [Related]

  • 12. Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo.
    Valrance ME, Brunet AH, Welsh J.
    Endocrinology; 2007 Oct 16; 148(10):4887-94. PubMed ID: 17628009
    [Abstract] [Full Text] [Related]

  • 13. Novel nonsecosteroidal vitamin D receptor modulator inhibits the growth of LNCaP xenograft tumors in athymic mice without increased serum calcium.
    Polek TC, Murthy S, Blutt SE, Boehm MF, Zou A, Weigel NL, Allegretto EA.
    Prostate; 2001 Nov 01; 49(3):224-33. PubMed ID: 11746268
    [Abstract] [Full Text] [Related]

  • 14. RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects.
    Yin Y, Ni J, Chen M, Guo Y, Yeh S.
    Clin Cancer Res; 2009 Jan 01; 15(1):190-200. PubMed ID: 19118046
    [Abstract] [Full Text] [Related]

  • 15. Effects of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and its analogues (EB1089 and analog V) on canine adenocarcinoma (CAC-8) in nude mice.
    Kunakornsawat S, Rosol TJ, Capen CC, Reddy GS, Binderup L, Inpanbutr N.
    Biol Pharm Bull; 2002 May 01; 25(5):642-7. PubMed ID: 12033506
    [Abstract] [Full Text] [Related]

  • 16. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
    Zinser GM, McEleney K, Welsh J.
    Mol Cell Endocrinol; 2003 Feb 28; 200(1-2):67-80. PubMed ID: 12644300
    [Abstract] [Full Text] [Related]

  • 17. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells.
    James SY, Mackay AG, Colston KW.
    J Steroid Biochem Mol Biol; 1996 Jul 28; 58(4):395-401. PubMed ID: 8903423
    [Abstract] [Full Text] [Related]

  • 18. EB1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro.
    Colston KW, Mackay AG, James SY, Binderup L, Chander S, Coombes RC.
    Biochem Pharmacol; 1992 Dec 15; 44(12):2273-80. PubMed ID: 1472092
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D receptor and p21/WAF1 are targets of genistein and 1,25-dihydroxyvitamin D3 in human prostate cancer cells.
    Rao A, Coan A, Welsh JE, Barclay WW, Koumenis C, Cramer SD.
    Cancer Res; 2004 Mar 15; 64(6):2143-7. PubMed ID: 15026355
    [Abstract] [Full Text] [Related]

  • 20. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089.
    VanWeelden K, Flanagan L, Binderup L, Tenniswood M, Welsh J.
    Endocrinology; 1998 Apr 15; 139(4):2102-10. PubMed ID: 9528999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.